In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Hepatology

• Publication date

  2003-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8278(03)00463-XPMID 14642624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol

  2002cited by this paper
• NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

  2002cited by this paper
• Leptin is essential for the hepatic fibrogenic response to chronic liver injury.

  2002cited by this paper
• Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

  2002cited by this paper
• Secretion of free and protein-bound leptin from subcutaneous adipose tissue of lean and obese women.

  2002cited by this paper
• Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans.

  2002cited by this paper
• Plasma Leptin and TNF-α Levels in Chronic Hepatitis C Patients and Their Relationship to Hepatic Fibrosis

  2002cited by this paper
• Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?

  2002cited by this paper
• Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C

  2002cited by this paper
• Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral‐related steatosis

  2002cited by this paper
• Leptin in hepatic fibrosis: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice

  2002cited by this paper
• Leptin and liver fibrosis: a matter of fat.

  2002cited by this paper
• Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

  2001cited by this paper
• Diagnosing insulin resistance in the general population.

  2001cited by this paper
• Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

  2001cited by this paper
• Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

  2001cited by this paper
• Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

  2001cited by this paper
• High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

  2001cited by this paper
• Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

  2001cited by this paper
• Translational regulation of renal proximal tubular epithelial cell transforming growth factor-beta1 generation by insulin.

  2001cited by this paper
• Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals

  2001cited by this paper
• Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

  2000cited by this paper
• Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C

  2000cited by this paper
• Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: Effect of liver transplantation

  2000cited by this paper
• Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

  2000cited by this paper
• Severity of HCV-Induced Liver Damage Alters Glucose Homeostasis in Noncirrhotic Patients with Chronic HCV Infection

  2000cited by this paper
• Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair.

  2000cited by this paper
• Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection.

  2000cited by this paper
• Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

  2000cited by this paper
• Prevalence of Type 2 Diabetes Mellitus among Persons with Hepatitis C Virus Infection in the United States

  2000cited by this paper
• Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.

  2000cited by this paper
• Insulin and insulin‐like growth factor‐1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways

  1999cited by this paper
• Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

  1999cited by this paper
• Association of nonalcoholic fatty liver disease with insulin resistance.

  1999cited by this paper
• Further evidence for an association between non–insulin‐dependent diabetes mellitus and chronic hepatitis C virus infection

  1999cited by this paper
• Association of diabetes mellitus and chronic hepatitis C virus infection

  1999cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults.

  1998cited by this paper
• Transdifferentiation of rat hepatic stellate cells results in leptin expression.

  1998cited by this paper
• Molecular mechanisms for the control of translation by insulin.

  1997cited by this paper
• Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

  1997cited by this paper
• Modulation of Insulin Activities by Leptin

  1996cited by this paper
• Classification of chronic viral hepatitis: a need for reassessment.

  1991cited by this paper
• Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.

  1991cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

  1977cited by this paper

• Assessment of hepatic fibrosis with non-invasive indices in subjects with diabetes before and after liver transplantation

  2024cites this paper
• Controlled Attenuation Parameter Is Associated with a Distinct Systemic Inflammatory Milieu after Clearance of HCV Infection

  2023cites this paper
• Immunohistochemical Study of Stellate Cells in Patients with Chronic Viral Heptitis C Histopathological study

  2023cites this paper
• Hepatitis C virus: A critical approach to who really needs treatment

  2022cites this paper
• Identifying the predictors of Covid-19 infection outcomes and development of prediction models

  2021cites this paper
• Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression

  2020cites this paper
• Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases

  2020cites this paper
• MRI estimated changes in visceral adipose tissue and liver fat fraction in patients with obesity during a very low-calorie-ketogenic diet compared to a standard low-calorie diet.

  2020cites this paper
• Insulin/high-density lipoprotein cholesterol ratio: A newly-discovered predictor of esophageal varices in patients with hepatitis C virus-related cirrhosis in the absence of diabetes mellitus.

  2020cites this paper
• Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review

  2019cites this paper
• Systematic review: chronic viral hepatitis and metabolic derangement

  2019cites this paper
• Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis

  2019cites this paper
• Metabolic Factors and Their Influence on the Clinical Course and Response to HCV Treatment

  2018cites this paper
• NATURAL HISTORY OF HEPATITIS C

  2018cites this paper
• Insulin resistance and hepatitis C infection: a bidirectional relationship independent of diabetes and metabolic syndrome

  2018cites this paper
• The association between steatosis and diabetes with hepatocellular carcinoma in non‐genotype 3 chronic hepatitis C patients

  2018cites this paper
• Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c

  2018cites this paper
• An Increase in Expression of SOCS1 Gene with Increase in Hepatitis C Virus Viral Load

  2018cites this paper
• IMPACT OF CIRRHOTIC LIVER DISEASE: BEYOND SIMPLE MEASURES OF MORTALITY AND MORBIDITY

  2018cites this paper
• INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES.

  2018cites this paper
• FACTORS REFRACTORY TO CONVENTIONAL INTERFERON BASED THERAPY IN CHRONIC HEPATITIS C

  2017cites this paper
• Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients

  2017cites this paper
• Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients

  2017cites this paper
• Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and Immunity

  2016cites this paper
• Metabolic alterations and hepatitis C: From bench to bedside.

  2016cites this paper
• Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?

  2016cites this paper
• Hepatitis C and insulin action: An intimate relationship.

  2016cites this paper
• Insulin Resistance in Patients with Chronic Hepatitis C

  2016cites this paper
• Hepatitis C Virus, Insulin Resistance, and Steatosis

  2016cites this paper
• The Multifaceted Features of HCV Infection Beyond the Liver

  2016cites this paper
• NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations

  2016cites this paper
• Aldose reductase (-106) C/T gene polymorphism and possibility of macrovascular complications in Egyptian type 2 diabetic patients

  2016cites this paper
• Determinant Factors of the Direct Medical Costs Associated with Genotype 1 Hepatitis C Infection in Treatment-Experienced Patients

  2015cites this paper
• Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilization-Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy

  2015cites this paper
• Assessment of host metabolic factors: Adiponectin, TNF - and Insulin resistance influence on the degree of hepatic steatosis in patients infected with Hepatitis C virus

  2015cites this paper
• Improving treatment predictors of HCV therapy and the impact of steatosis on the hepatocyte transcriptome and anti-HCV action of interferon

  2015cites this paper
• Natural History of Hepatitis C.

  2015cites this paper
• Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma

  2015cites this paper
• Acute and chronic immune biomarker changes during interferon/ribavirin treatment in HIV/HCV co‐infected patients

  2015cites this paper
• Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study.

  2015cites this paper
• Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis.

  2015cites this paper
• Factors associated with steatosis in liver biopsies of individuals with chronic hepatitis C infection in southern Brazil.

  2015cites this paper
• A Descriptive Case Series Study to Evaluate the Association of Hepatitis C Virus Infection with Insulin Resistance

  2014cites this paper
• Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.

  2014cites this paper
• The association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C: an observational, multicenter study in Turkey.

  2014influential citation
• Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection

  2014cites this paper
• On the assessment and impact of liver fibrosis in patients with chronic hepatitis C

  2013cites this paper
• Preliminary study of the level of visfatin and the relationship with insulin resistance in Chinese patients with chronic hepatitis C.

  2013cites this paper
• Role of viral and host factors in interferon based therapy of hepatitis C virus infection

  2013cites this paper
• Serum RANTES level influences the response to pegylated interferon and ribavirin therapy in chronic hepatitis C

  2013cites this paper
• Insulin resistance and Hepatitis C virus infection : Risk factors and correlation to the degree of liver injury

  2013cites this paper
• Rapid virological response as a predictor of a sustained virological response in Egyptian patients with chronic hepatitis C genotype 4

  2013cites this paper
• Insulin resistance and early virological response in chronic HCV infection

  2013cites this paper
• Serology for hepatitis B and C, HIV and syphilis in the initial evaluation of diabetes patients referred for an external nephrology consultation.

  2013cites this paper
• Recurrent hepatitis C and non-alcoholic fatty liver disease in transplanted patients: a review.

  2013cites this paper
• Responses to glycemic control therapy according to age, gender, level of adiposity, and duration of diabetes in type 2 diabetic patients.

  2013cites this paper
• Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007–2011

  2013cites this paper
• S INDEX IN HCV-RNA POSITIVE P

  2012cites this paper
• Type 2 diabetes mellitus and chronic hepatitis C: which is worse? Results of a long-term retrospective cohort study.

  2012cites this paper
• ASSOCIATION OF PRETREATMENT LIVER HISTOLOGY WITH SERUM ALANINE AMINOTRANSFERASE LEVEL AND BODY MASS INDEX IN HCV-RNA POSITIVE PATIENTS

  2012cites this paper
• The effect of age, gender, level of adiposity and diabetes duration on glycated hemoglobin reduction after anti-diabetic therapy in type-2 diabetic patients

  2012cites this paper
• Steatosis and insulin resistance in response to treatment of chronic hepatitis C

  2012cites this paper
• echanisms of hepatitis C virus-related insulin esistance

  2011cites this paper
• The role of JAZF1 on lipid metabolism and related genes in vitro.

  2011cites this paper
• On the outcome of antiviral therapy for hepatitis C virus genotype 2 or 3 infection

  2011cites this paper
• Mechanisms of hepatitis C virus-related insulin resistance.

  2011cites this paper
• HCV synergizes with body weight in the promotion of insulin resistance

  2011cites this paper
• Interleukin‐32: A new proinflammatory cytokine involved in hepatitis C virus‐related liver inflammation and fibrosis

  2011cites this paper
• Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3

  2011cites this paper
• Mild Alcohol Consumption is Not Associated With Increased Fibrosis in Patients With Chronic Hepatitis C

  2011cites this paper
• The Impact of Exercise and Nutrition on the Outcome of Patients with Chronic Hepatitis C HEPATITIS C : A NEW ERA OF TREATMENT , SERIES # 2

  2011cites this paper
• The role of lifestyle changes in the management of chronic liver disease

  2011cites this paper
• Can exercise be a new approach for chronic hepatitis C?

  2011cites this paper
• Current understanding of insulin resistance in hepatitis C

  2011cites this paper
• Evolution of Interferon-Based Therapy for Chronic Hepatitis C

  2010cites this paper
• The importance of steatosis in chronic hepatitis C infection and its management: A review

  2010cites this paper
• Hepatitis C Virus-Induced Steatosis: An Overview

  2010cites this paper
• Restriction of calorie and iron intake results in reduction of visceral fat and serum alanine aminotransferase and ferritin levels in patients with chronic liver disease

  2010cites this paper
• Role of adipocytokines in hepatic fibrosis.

  2010cites this paper
• Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection

  2010cites this paper
• Hepatocyte steatosis in patients infected with genotype 1 hepatitis C virus.

  2010cites this paper
• Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients.

  2010cites this paper
• Steatosis as a co-factor in chronic liver diseases.

  2010cites this paper
• Metabolic Factors and Non-Alcoholic Fatty Liver Disease as Co-Factors in Other Liver Diseases

  2010cites this paper
• Metabolic Implications of Hepatitis C Virus Infection and it's Correlation to Steatohepatitis in Chronic Hepatitis C Patients with and without Type 2 Diabetes

  2010cites this paper
• Secondary Causes of Diabetes Mellitus

  2010cites this paper
• Viral Infections by Nonhepatotropic Viruses

  2010cites this paper
• Hepatocyte steatosis in patients infected with genotype 1 hepatitis C virus

  2010cites this paper
• Hepatitis C virus and type 2 diabetes.

  2009cites this paper
• Patients achieving clearance of HCV with interferon therapy recover from decreased retinol‐binding protein 4 levels

  2009cites this paper
• Liver fibrosis and therapeutic strategies: the goal for improving metabolism.

  2009cites this paper
• Review: Predicting the probable outcome of treatment in HCV patients

  2009cites this paper
• Hepatitis C virus and glucose and lipid metabolism

  2009cites this paper
• Change of insulin sensitivity in hepatitis C patients with normal insulin sensitivity; a 5‐year prospective follow‐up study variation of insulin sensitivity in HCV patients

  2009cites this paper
• Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus

  2009cites this paper
• Fat and viral liver disease

  2009cites this paper
• Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono‐infected compared with HIV–HCV co‐infected patients

  2009cites this paper
• Influence of body mass index, cholesterol, triglycerides and steatosis on pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C in patients transplanted for HCV and alcoholic cirrhosis.

  2009cites this paper
• Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.

  2008cites this paper
• Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C

  2008cites this paper